Lanean...
Evaluation of the Clinical Benefit of Cancer Drugs Submitted for Reimbursement Recommendation Decisions in Canada
IMPORTANCE: Cancer drugs approved by the US Food and Drug Administration have come under scrutiny for marginal clinical benefits; however, the clinical benefits of cancer drugs recommended for reimbursement in Canada have not been adequately studied. OBJECTIVE: To assess the differences in the clini...
Gorde:
| Argitaratua izan da: | JAMA Intern Med |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
American Medical Association
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7900938/ https://ncbi.nlm.nih.gov/pubmed/33616606 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamainternmed.2020.8588 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|